PGRMC1 and breast carcinoma: PGRMC1 was demonstrated to confer progestin responsiveness, which results in enhanced proliferation of MCF7 breast cancer cells in vitro and in vivo [27,29,30], indicating a potential role of PGRMC1 in increased breast cancer risk upon progestin-based HT [31].